Virginie Van Scherpenzeel Thim

Title: Virginie Van Scherpenzeel Thim: Innovator in Vaccine Development

Introduction

Virginie Van Scherpenzeel Thim is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of immunology, particularly in the development of vaccines. Her work focuses on creating innovative solutions to combat viral infections.

Latest Patents

Virginie holds a patent for a vaccine that provides immunogenic compositions. This patent includes at least two paramyxovirus F protein antigens selected from human metapneumovirus (hMPV), parainfluenza virus (PIV), and respiratory syncytial virus (RSV). The antigens in her compositions are recombinant F protein polypeptides, modified to stabilize the trimeric prefusion conformation. Additionally, the patent covers nucleic acids encoding the antigens, along with methods for their production and use. She has 1 patent to her name.

Career Highlights

Virginie is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. Her role involves extensive research and development in vaccine technology, contributing to advancements in public health.

Collaborations

Throughout her career, Virginie has collaborated with esteemed colleagues, including Ventzislav Bojidarov Vassilev and Normand Blais. These partnerships have enhanced her research efforts and broadened the impact of her work.

Conclusion

Virginie Van Scherpenzeel Thim is a pioneering inventor in the field of vaccine development, with a focus on innovative immunogenic compositions. Her contributions are vital in the ongoing fight against viral diseases, showcasing her dedication to improving global health.